Serum Krebs von den Lungen-6 concentrations reflect severity of anti-melanoma differentiation-associated protein 5 antibody positive dermatomyositis associated interstitial lung disease-Reference-Cited by-同舟云学术

Serum Krebs von den Lungen-6 concentrations reflect severity of anti-melanoma differentiation-associated protein 5 antibody positive dermatomyositis associated interstitial lung disease

Published:2022-02-25 Issue:2 Volume:40 Page:292-297
ISSN:1593-098X
Container-title:Clinical and Experimental Rheumatology
language:en
Short-container-title:

Author:

Zhu Yujing¹,Wang Lei¹,Sun Yuankai¹,Wang Jiajia¹,Lv Chengyin¹,You Hanxiao¹,Xu Lingxiao¹,Wang Fang²,Zhang Miaojia¹,Tan Wenfeng³,Ke Yao⁴

Affiliation:

1. Department of Rheumatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.

2. Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.

3. Department of Rheumatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China. tw2006@njmu.edu.cn

4. Department of Rheumatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China. fenny.ok@163.com

Publisher

Clinical and Experimental Rheumatology

Subject

Immunology,Immunology and Allergy,Rheumatology

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum KL-6 and the mortality of patients with connective tissue disease-associated interstitial lung disease: A meta-analysis;Biomolecules and Biomedicine;2024-09-06

2. Rapidly progressive interstitial lung disease risk prediction in anti-MDA5 positive dermatomyositis: the CROSS model;Frontiers in Immunology;2024-02-01

3. Progressive pulmonary fibrosis in myositis-specific antibody-positive interstitial pneumonia: a retrospective cohort study;Frontiers in Medicine;2024-01-11

4. Proteomic profiling identifies SPP1 associated with rapidly progressive interstitial lung disease in anti-MDA5-positive dermatomyositis;Arthritis Research & Therapy;2024-01-02

5. Anti-MDA5 antibody-positive dermatomyositis: pathogenesis and clinical progress;Nature Reviews Rheumatology;2023-12-06